{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:24:30Z","timestamp":1792628670288,"version":"4.5.0"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Acetaminophen (APAP) overdose is a significant cause of drug-induced liver injury and acute liver failure. The diagnosis, screening, and management of APAP-induced liver injury (AILI) is challenging because of the complex mechanisms involved. Starting from the current studies on the mechanisms of AILI, this review focuses on novel findings in the field of diagnosis, screening, and management of AILI. It highlights the current issues that need to be addressed. This review is supposed to summarize the recent research progress and make recommendations for future research.<\/jats:p>","DOI":"10.3389\/fphar.2023.1239395","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T05:41:53Z","timestamp":1691127713000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Advances in the study of acetaminophen-induced liver injury"],"prefix":"10.3389","volume":"14","author":[{"given":"Xinghui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1016\/S0168-8278(20)30766-2","article-title":"Liver toxicity in the Phase 2 Catalyst 206 trial of Inarigivir 400 mg daily added to a nucleoside in HBV EAg negative patients","volume":"73","author":"Agarwal","year":"2020","journal-title":"J. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/md12010128","article-title":"Astaxanthin: Sources, extraction, stability, biological activities and its commercial applications-A review","volume":"12","author":"Ambati","year":"2014","journal-title":"Mar. Drugs"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: Drug-induced liver injury","volume":"70","author":"Andrade","year":"","journal-title":"J. Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/hep.26294","article-title":"Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital","volume":"58","author":"Antoine","year":"2013","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1080\/19420862.2017.1373924","article-title":"Capacity limits of asialoglycoprotein receptor-mediated liver targeting","volume":"9","author":"Bon","year":"2017","journal-title":"mAbs-Austin"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.ajpath.2018.03.006","article-title":"Pleiotropic role of p53 in injury and liver regeneration after acetaminophen overdose","volume":"188","author":"Borude","year":"2018","journal-title":"Am. J. Pathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jhep.2013.03.033","article-title":"Decoding cell death signals in liver inflammation","volume":"59","author":"Brenner","year":"2013","journal-title":"J. Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1631\/jzus.B2100977","article-title":"Molecular pathogenesis of acetaminophen-induced liver injury and its treatment options","volume":"23","author":"Cai","year":"","journal-title":"J. Zhejiang Univ.-Sc. B"},{"key":"B10","doi-asserted-by":"publisher","first-page":"42887","DOI":"10.1021\/acsami.2c10506","article-title":"Astaxanthin activated the Nrf2\/HO-1 pathway to enhance autophagy and inhibit ferroptosis, ameliorating acetaminophen-induced liver injury","volume":"14","author":"Cai","year":"","journal-title":"ACS Appl. Mat. Inter."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"878","DOI":"10.14309\/ajg.0000000000001259","article-title":"ACG clinical guideline: Diagnosis and management of idiosyncratic drug-induced liver injury","volume":"116","author":"Chalasani","year":"2021","journal-title":"Am. J. Coll. Gastroenter."},{"key":"B13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jhep.2022.10.028","article-title":"Hepatocyte-specific Mas activation enhances lipophagy and fatty acid oxidation to protect against acetaminophen-induced hepatotoxicity in mice","volume":"78","author":"Chen","year":"2023","journal-title":"J. Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"bbab503","DOI":"10.1093\/bib\/bbab503","article-title":"ResNet18DNN: Prediction approach of drug-induced liver injury by deep neural network with ResNet18","volume":"23","author":"Chen","year":"2022","journal-title":"Brief. Bioinform."},{"key":"B15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.5694\/mja2.50428","article-title":"Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand","volume":"212","author":"Chiew","year":"2020","journal-title":"Med. J. Aust."},{"key":"B16","doi-asserted-by":"publisher","first-page":"105102","DOI":"10.1016\/j.phrs.2020.105102","article-title":"Current etiological comprehension and therapeutic targets of acetaminophen-induced hepatotoxicity","volume":"161","author":"Chowdhury","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/hep.29802","article-title":"Candidate biomarkers for the diagnosis and prognosis of drug\u2010induced liver injury: An international collaborative effort","volume":"69","author":"Church","year":"2019","journal-title":"Hepatology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1111\/liv.13441","article-title":"The transformation in biomarker detection and management of drug-induced liver injury","volume":"37","author":"Church","year":"2017","journal-title":"Liver Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1365-2036.2009.04175.x","article-title":"Review article: The current management of acute liver failure","volume":"31","author":"Craig","year":"2010","journal-title":"Aliment. Pharm. Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jconrel.2015.02.022","article-title":"Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications","volume":"203","author":"D'Souza","year":"2015","journal-title":"J. Control. Release"},{"key":"B21","doi-asserted-by":"publisher","first-page":"30269","DOI":"10.3390\/ijms161226225","article-title":"Oxidative stress and inflammation in hepatic diseases: Therapeutic possibilities of N-acetylcysteine","volume":"16","author":"de Andrade","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s12072-021-10144-3","article-title":"Drug-induced liver injury: Asia pacific association of study of liver consensus guidelines","volume":"15","author":"Devarbhavi","year":"2021","journal-title":"Hepatol. Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.redox.2016.10.001","article-title":"Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential","volume":"10","author":"Du","year":"2016","journal-title":"Redox Bio"},{"key":"B24","doi-asserted-by":"publisher","first-page":"270418","DOI":"10.1155\/2013\/270418","article-title":"Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: The evidence so far","volume":"2013","author":"Esp\u00edn","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.7150\/ijbs.69116","article-title":"Urolithin A protects against acetaminophen-induced liver injury in mice via sustained activation of Nrf2","volume":"18","author":"Gao","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1007\/s00204-020-02885-1","article-title":"Drug induced liver injury: An update","volume":"94","author":"Garcia-Cortes","year":"2020","journal-title":"Arch. Toxicol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/hep.20183","article-title":"Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice","volume":"39","author":"Goldring","year":"2004","journal-title":"Hepatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/hep.0000000000000044","article-title":"Scavenger receptor a is a major homeostatic regulator that restrains drug-induced liver injury","volume":"78","author":"Guo","year":"9900","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"14109","DOI":"10.1073\/pnas.1612668113","article-title":"Role of the receptor Mas in macrophage-mediated inflammation in vivo","volume":"113","author":"Hammer","year":"2016","journal-title":"P. Natl. Acad. Sci. U. S. A."},{"key":"B30","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2021.10.017","article-title":"Membrane-delimited signaling and cytosolic action of MG53 preserve hepatocyte integrity during drug-induced liver injury","volume":"76","author":"Han","year":"2022","journal-title":"J. Hepatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/hep.32327","article-title":"A revised electronic version of RUCAM for the diagnosis of DILI","volume":"76","author":"Hayashi","year":"2022","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1056\/NEJMct0708278","article-title":"Acetylcysteine for acetaminophen poisoning","volume":"359","author":"Heard","year":"2008","journal-title":"New Engl. J. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/ajg.2016.114","article-title":"Clinical features and outcomes of complementary and alternative medicine induced acute liver failure and injury","volume":"111","author":"Hillman","year":"2016","journal-title":"Am. J. Gastroenterol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/pharmaceutics11030129","article-title":"Challenges and recent progress in oral drug delivery systems for biopharmaceuticals","volume":"11","author":"Homayun","year":"2019","journal-title":"Pharmaceutics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"17562848231163410","DOI":"10.1177\/17562848231163410","article-title":"Drug-induced liver injury: A comprehensive review","volume":"16","author":"Hosack","year":"2023","journal-title":"Ther. Adv. Gastroenter."},{"key":"B36","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/toxsci\/kfv319","article-title":"Low dose acetaminophen induces reversible mitochondrial dysfunction associated with transient c-jun N-terminal kinase activation in mouse liver","volume":"150","author":"Hu","year":"2016","journal-title":"Toxicol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2017.02.028","article-title":"Protective role of p53 in acetaminophen hepatotoxicity","volume":"106","author":"Huo","year":"2017","journal-title":"Free Radic. Bio. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An nrf2\/small maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem. Bioph. Res. Co."},{"key":"B39","doi-asserted-by":"publisher","first-page":"111240","DOI":"10.1016\/j.fct.2020.111240","article-title":"Mechanisms and pathophysiological significance of sterile inflammation during acetaminophen hepatotoxicity","volume":"138","author":"Jaeschke","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1038\/ncomms5387","article-title":"Treatment of acute lung injury by targeting MG53-mediated cell membrane repair","volume":"5","author":"Jia","year":"2014","journal-title":"Nat. Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3109\/07388551.2014.930017","article-title":"Liver cell-targeted delivery of therapeutic molecules","volume":"36","author":"Kang","year":"2016","journal-title":"Crit. Rev. Biotechnol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/toxsci\/kfq175","article-title":"Lysosomal iron mobilization and induction of the mitochondrial permeability transition in acetaminophen-induced toxicity to mouse hepatocytes","volume":"117","author":"Kon","year":"2010","journal-title":"Toxicol. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1007\/s00204-021-03121-0","article-title":"The application of cytokeratin-18 as a biomarker for drug-induced liver injury","volume":"95","author":"Korver","year":"2021","journal-title":"Arch. Toxicol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000367","article-title":"Role of HNF4alpha-cMyc interaction in liver regeneration and recovery after acetaminophen-induced acute liver injury","author":"Kotulkar","year":"9900","journal-title":"Hepatology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrm4007","article-title":"p53 in survival, death and metabolic health: a lifeguard with a licence to kill","volume":"16","author":"Kruiswijk","year":"2015","journal-title":"Nat. Rev. Mol. Cell Bio."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/jobm.202100391","article-title":"Astaxanthin: A super antioxidant from microalgae and its therapeutic potential","volume":"62","author":"Kumar","year":"2022","journal-title":"J. Basic Microb."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.03.002","article-title":"The role of carbamoyl phosphate synthetase 1 as a prognostic biomarker in patients with acetaminophen-induced acute liver failure","author":"Kwan","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00204-014-1432-2","article-title":"Acetaminophen hepatotoxicity: An updated review","volume":"89","author":"Lancaster","year":"2015","journal-title":"Arch. Toxicol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0168-8278(00)80417-1","article-title":"Drug-induced liver diseases","volume":"32","author":"Larrey","year":"2000","journal-title":"J. Hepatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/hep.20948","article-title":"Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study","volume":"42","author":"Larson","year":"2005","journal-title":"Hepatology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.clinbiochem.2015.04.017","article-title":"A review on the possible molecular mechanism of action of N-acetylcysteine against insulin resistance and type-2 diabetes development","volume":"48","author":"Lasram","year":"2015","journal-title":"Clin. Biochem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"105677","DOI":"10.1016\/j.isci.2022.105677","article-title":"Supervised chemical graph mining improves drug-induced liver injury prediction","volume":"26","author":"Lim","year":"2023","journal-title":"iScience"},{"key":"B53","doi-asserted-by":"publisher","first-page":"990087","DOI":"10.3389\/fphar.2022.990087","article-title":"Inhibition of inflammatory liver injury by the HMGB1-A box through HMGB1\/TLR-4\/NF-\u03baB signaling in an acute liver failure mouse model","volume":"13","author":"Luo","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/hep.510260319","article-title":"Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis","volume":"26","author":"Maria","year":"1997","journal-title":"Hepatology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.drudis.2011.04.011","article-title":"A generic operational strategy to qualify translational safety biomarkers","volume":"16","author":"Matheis","year":"2011","journal-title":"Drug Discov. Today"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1007\/s11095-013-1007-6","article-title":"Metabolism and disposition of acetaminophen: Recent advances in relation to hepatotoxicity and diagnosis","volume":"30","author":"Mcgill","year":"2013","journal-title":"Pharm. Res.-Dordr."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1172\/JCI59755","article-title":"The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation","volume":"122","author":"Mcgill","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.3390\/ijms19103104","article-title":"Danger-associated molecular patterns (DAMPs): Molecular triggers for sterile inflammation in the liver","volume":"19","author":"Mihm","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e626","DOI":"10.1038\/cddis.2013.150","article-title":"Protein tyrosine phosphatase 1B modulates GSK3\u03b2\/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity","volume":"4","author":"Mobasher","year":"2013","journal-title":"Cell Death Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3389\/fphar.2018.00453","article-title":"Mitochondrial-lysosomal Axis in acetaminophen hepatotoxicity","volume":"9","author":"Moles","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3390\/metabo12060564","article-title":"The potential role of metabolomics in drug-induced liver injury (DILI) assessment","volume":"12","author":"Moreno-Torres","year":"2022","journal-title":"Metabolites"},{"key":"B62","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1089\/ten.teb.2007.0332","article-title":"Cell encapsulation in biodegradable hydrogels for tissue engineering applications","volume":"14","author":"Nicodemus","year":"2008","journal-title":"Tissue Eng. Part. B-Re"},{"key":"B63","doi-asserted-by":"publisher","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.yrtph.2009.11.001","article-title":"Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injury","volume":"56","author":"Ozer","year":"2010","journal-title":"Regul. Toxicol. Pharm."},{"key":"B65","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/nbt.3313","article-title":"Deep learning for regulatory genomics","volume":"33","author":"Park","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e10486","DOI":"10.1002\/btm2.10486","article-title":"Galactosylatedhydroxyl-polyamidoamine dendrimer targets hepatocytes and improves therapeutic outcomes in a severe model of acetaminophen poisoning\u2010induced liver failure","volume":"8","author":"Porterfield","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/gels7040153","article-title":"Development of a polysaccharide-based hydrogel drug delivery system (DDS): An update","volume":"7","author":"Pushpamalar","year":"2021","journal-title":"Gels"},{"key":"B68","doi-asserted-by":"publisher","first-page":"17940","DOI":"10.1074\/jbc.273.28.17940","article-title":"Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry","volume":"273","author":"Qiu","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1007\/s00204-021-03114-z","article-title":"Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes","volume":"95","author":"Quint\u00e1s","year":"2021","journal-title":"Arch. Toxicol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/s41467-023-36858-6","article-title":"Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans","volume":"14","author":"Ravindra","year":"2023","journal-title":"Nat. Commun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1111\/tri.14128","article-title":"Organoid transplant approaches for the liver","volume":"34","author":"Reza","year":"2021","journal-title":"Transpl. Int."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/hep.23577","article-title":"Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment method","volume":"51","author":"Rockey","year":"2010","journal-title":"Hepatology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/lt.20204","article-title":"Liver transplantation for acute liver failure from drug induced liver injury in the United States","volume":"10","author":"Russo","year":"2004","journal-title":"Liver Transpl."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1136\/gut.2008.163675","article-title":"Diagnosis, management and prevention of drug-induced liver injury","volume":"58","author":"S","year":"2009","journal-title":"Gut"},{"key":"B75","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/hep.23267","article-title":"Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine","volume":"51","author":"Saito","year":"2010","journal-title":"Hepatology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1\u20137)\/MAS Axis of the renin-angiotensin system: Focus on angiotensin-(1\u20137)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"B77","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: A French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10404-019-2261-7","article-title":"Bone-chip system to monitor osteogenic differentiation using optical imaging","volume":"23","author":"Sheyn","year":"2019","journal-title":"Microfluid. Nanofluid."},{"key":"B79","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.1093\/bioinformatics\/btac490","article-title":"ToxSTAR: Drug-induced liver injury prediction tool for the web environment","volume":"38","author":"Shin","year":"2022","journal-title":"Bioinformatics"},{"key":"B80","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1053\/j.gastro.2020.10.002","article-title":"High-fidelity drug-induced liver injury screen using human pluripotent stem cell-derived organoids","volume":"160","author":"Shinozawa","year":"2021","journal-title":"Gastroenterology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1124\/dmd.31.9.1176","article-title":"Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites","volume":"31","author":"Slitt","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e2206789","DOI":"10.1002\/advs.202206789","article-title":"Circulating cell\u2010free DNAs as a biomarker and therapeutic target for acetaminophen\u2010induced liver injury","volume":"10","author":"Sun","year":"2023","journal-title":"Adv. Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"106361","DOI":"10.1016\/j.phrs.2022.106361","article-title":"Progress in the treatment of drug-induced liver injury with natural products","volume":"183","author":"Sun","year":"2022","journal-title":"Pharmacol. Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/clpt.2014.110","article-title":"Human iPSC-derived miniature organs: A tool for drug studies","volume":"96","author":"Takebe","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1038\/519S19a","article-title":"Perspective: Special delivery for the gut","volume":"519","author":"Traverso","year":"2015","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nrgastro.2011.22","article-title":"Mechanisms of drug-induced liver injury: From bedside to bench","volume":"8","author":"Tujios","year":"2011","journal-title":"Nat. Rev. Gastro. Hepat."},{"key":"B87","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/liv.13535","article-title":"Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy","volume":"38","author":"Tujios","year":"2018","journal-title":"Liver Int."},{"key":"B88","doi-asserted-by":"publisher","first-page":"638410","DOI":"10.3389\/frai.2021.638410","article-title":"The promise of AI for DILI prediction","volume":"4","author":"Vall","year":"2021","journal-title":"Front. Artif. Intell."},{"key":"B89","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3390\/livers1040022","article-title":"Redrawing the map to novel DILI biomarkers in circulation: Where are we, where should we go, and how can we get there?","volume":"1","author":"Vazquez","year":"2021","journal-title":"Livers"},{"key":"B90","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/clpt.2011.63","article-title":"Drug safety sciences and the bottleneck in drug development","volume":"89","author":"Watkins","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/hep.22633","article-title":"Using controlled clinical trials to learn more about acute drug-induced liver injury","volume":"48","author":"Watkins","year":"2008","journal-title":"Hepatology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41573-019-0048-x","article-title":"Managing the challenge of drug-induced liver injury: A roadmap for the development and deployment of preclinical predictive models","volume":"19","author":"Weaver","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"B93","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ceb.2007.02.001","article-title":"The JNK signal transduction pathway","volume":"19","author":"Weston","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/hep.28486","article-title":"c-Jun N-terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)-dependent pathway leading to inactivation of intramitochondrial Src","volume":"63","author":"Win","year":"2016","journal-title":"Hepatology"},{"key":"B95","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.dmpk.2016.11.008","article-title":"The role of quantitative systems pharmacology modeling in the prediction and explanation of idiosyncratic drug-induced liver injury","volume":"32","author":"Woodhead","year":"2017","journal-title":"Drug Metab. pharmacok."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1111\/liv.13131","article-title":"Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease","volume":"36","author":"Wu","year":"2016","journal-title":"Liver Int."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1021\/acs.jcim.5b00238","article-title":"Deep learning for drug-induced liver injury","volume":"55","author":"Xu","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"B98","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.redox.2018.04.019","article-title":"Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions","volume":"17","author":"Yan","year":"2018","journal-title":"Redox Bio"},{"key":"B99","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/hep.27060","article-title":"Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1\u03b1-mediated antioxidant capacity in mice","volume":"60","author":"Ye","year":"2014","journal-title":"Hepatology"},{"key":"B100","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.carbpol.2018.06.086","article-title":"Carrageenan based hydrogels for drug delivery, tissue engineering and wound healing","volume":"198","author":"Yegappan","year":"2018","journal-title":"Carbohyd. Polym."},{"key":"B101","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1124\/dmd.121.000732","article-title":"Novel clinical biomarkers for drug-induced liver injury","volume":"50","author":"Youhao","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"B102","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jhep.2023.01.019","article-title":"A human liver organoid screening platform for DILI risk prediction","volume":"78","author":"Zhang","year":"2023","journal-title":"J. Hepatol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle\u2013liver interactions: Cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"B104","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13020-021-00543-x","article-title":"Mechanism of drug-induced liver injury and hepatoprotective effects of natural drugs","volume":"16","author":"Zhou","year":"2021","journal-title":"Chin. Med.-UK"},{"key":"B105","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S1089-3261(05)70097-0","article-title":"Drug-induced liver disease","volume":"4","author":"Zimmerman","year":"2000","journal-title":"Clin. Liver Dis."}],"updated-by":[{"DOI":"10.3389\/fphar.2023.1283596","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1239395\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T04:54:24Z","timestamp":1695272064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1239395\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":105,"alternative-id":["10.3389\/fphar.2023.1239395"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1239395","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"article-number":"1239395"}}